Tuttle Capital Management, LLC Abb Vie Inc. Transaction History

Tuttle Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $613,269 - $683,217	-5,829 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $596,306 - $656,461	5,829 New	5,829 $631,000
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $1.52 Million - $2.06 Million	-18,926 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $494,841 - $580,780	5,760 Added 43.75%	18,926 $1.66 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $965,989 - $1.29 Million	13,166 New	13,166 $1.29 Million
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $1.14 Million - $1.73 Million	-17,642 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $1.27 Million - $1.59 Million	17,642 New	17,642 $1.56 Million

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.